These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15780706)

  • 1. Pharmaceuticals: a threat to drinking water?
    Jones OA; Lester JN; Voulvoulis N
    Trends Biotechnol; 2005 Apr; 23(4):163-7. PubMed ID: 15780706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant.
    Stackelberg PE; Furlong ET; Meyer MT; Zaugg SD; Henderson AK; Reissman DB
    Sci Total Environ; 2004 Aug; 329(1-3):99-113. PubMed ID: 15262161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of so called organic trace compounds in drinking water from the regulatory, health and aesthetic-quality points of view, with special consideration given to pharmaceuticals].
    Dieter HH; Mückter H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Mar; 50(3):322-31. PubMed ID: 17334888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic dose as the point of departure in assessing potential health hazards from drugs in drinking water and recycled municipal wastewater.
    Bull RJ; Crook J; Whittaker M; Cotruvo JA
    Regul Toxicol Pharmacol; 2011 Jun; 60(1):1-19. PubMed ID: 20056125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to comment on "persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant".
    Stackelberg PE; Furlong ET; Meyer MT; Zaugg SD; Henderson AK; Reissman DB
    Sci Total Environ; 2006 Jan; 354(1):93-7. PubMed ID: 15913713
    [No Abstract]   [Full Text] [Related]  

  • 6. Invisible pollution: the impact of pharmaceuticals in the water supply.
    Strauch KA
    AAOHN J; 2011 Dec; 59(12):525-32; quiz 533. PubMed ID: 22132751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complex sanitary and hygienic evaluation of water supply and community health in the area of the sulfite cellulose plants].
    Seliuzhitskiĭ GV; Voro'beva LV; Chernova GI; Malevannyĭ IN; Rygalin MA; Klimenko AT; Zanin IuS; Ermolaeva-Makovskaia AP; Poty'lchanskaia OL; Voronin SF
    Gig Sanit; 1989 Aug; (8):10-3. PubMed ID: 2531696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A pilot study for the assessment of pharmaceuticals as water contaminants].
    Bottoni P; Fidente R
    Ann Ist Super Sanita; 2005; 41(3):333-42. PubMed ID: 16552124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of pharmaceuticals and other organic compounds in chlorinated drinking water as a function of time.
    Gibs J; Stackelberg PE; Furlong ET; Meyer M; Zaugg SD; Lippincott RL
    Sci Total Environ; 2007 Feb; 373(1):240-9. PubMed ID: 17188338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fate and removal of estrogens in municipal wastewater.
    Racz L; Goel RK
    J Environ Monit; 2010 Jan; 12(1):58-70. PubMed ID: 20082000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents.
    Esplugas S; Bila DM; Krause LG; Dezotti M
    J Hazard Mater; 2007 Nov; 149(3):631-42. PubMed ID: 17826898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs, diagnostic agents and disinfectants in wastewater and water--a review.
    Kümmerer K
    Schriftenr Ver Wasser Boden Lufthyg; 2000; 105():59-71. PubMed ID: 10842795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of micropollutants and reduction of biological activity in a full scale reclamation plant using ozonation and activated carbon filtration.
    Reungoat J; Macova M; Escher BI; Carswell S; Mueller JF; Keller J
    Water Res; 2010 Jan; 44(2):625-37. PubMed ID: 19863988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada.
    Boyd GR; Reemtsma H; Grimm DA; Mitra S
    Sci Total Environ; 2003 Jul; 311(1-3):135-49. PubMed ID: 12826389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine disruptors and pharmaceuticals: implications for water sustainability.
    Snyder SA; Benotti MJ
    Water Sci Technol; 2010; 61(1):145-54. PubMed ID: 20057100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse pollution of surface water by pharmaceutical products.
    Derksen JG; Rijs GB; Jongbloed RH
    Water Sci Technol; 2004; 49(3):213-21. PubMed ID: 15053118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters.
    Kim SD; Cho J; Kim IS; Vanderford BJ; Snyder SA
    Water Res; 2007 Mar; 41(5):1013-21. PubMed ID: 16934312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation products of pharmaceuticals in surface waters and wastewater formed during photolysis and advanced oxidation processes - degradation, elucidation of byproducts and assessment of their biological potency.
    Fatta-Kassinos D; Vasquez MI; Kümmerer K
    Chemosphere; 2011 Oct; 85(5):693-709. PubMed ID: 21835425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pollution of water sources and removal of pollutants by advanced drinking-water treatment in China.
    Wang L; Wang B
    Schriftenr Ver Wasser Boden Lufthyg; 2000; 105():413-9. PubMed ID: 10842847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the risk of ballast water treatment to human health.
    Banerji S; Werschkun B; Höfer T
    Regul Toxicol Pharmacol; 2012 Apr; 62(3):513-22. PubMed ID: 22107915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.